Peptides Similar to Dihexa

Peptides Related to Dihexa#

Dihexa occupies a unique position among cognitive peptides as an orally bioavailable compound that potentiates growth factor signaling rather than directly modulating neurotransmitter systems. The following comparison examines cognitive and neuroprotective peptides with overlapping research applications.

Semax#

Semax is a heptapeptide analog of ACTH(4-7) (Met-Glu-His-Phe-Pro-Gly-Pro) developed in Russia with over two decades of clinical use for cognitive enhancement and stroke recovery. Unlike dihexa's growth factor potentiation mechanism, semax upregulates BDNF expression and modulates serotonergic and dopaminergic neurotransmission.

Semax has a substantially stronger evidence base than dihexa, including clinical use in Russia and randomized controlled trials. However, semax requires intranasal administration and has a shorter duration of action, while dihexa is orally bioavailable. The mechanisms are complementary rather than overlapping: semax acts through neurotransmitter and BDNF pathways, while dihexa acts through HGF/c-Met signaling.

Cerebrolysin#

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It requires intravenous administration and has been studied in clinical trials for stroke recovery, traumatic brain injury, and Alzheimer's disease, with approval in several countries outside the United States.

Compared to dihexa, cerebrolysin has vastly more clinical evidence but is an undefined mixture rather than a single defined compound. Dihexa's oral bioavailability and defined mechanism represent potential advantages for drug development, though dihexa's evidence base is far weaker.

PE-22-28#

PE-22-28 (Mini-Spadin) is a heptapeptide TREK-1 channel antagonist that promotes rapid BDNF expression and neurogenesis. Like dihexa, it remains entirely preclinical with no human clinical trials. Both compounds promote neuroplasticity through different mechanisms: PE-22-28 through ion channel modulation and BDNF upregulation, and dihexa through HGF/c-Met potentiation.

Selank#

Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, developed in Russia as an anxiolytic and nootropic agent. It is clinically approved in Russia for anxiety disorders. While both selank and dihexa have nootropic properties, selank's primary therapeutic target is anxiety rather than cognitive enhancement, and its mechanism involves GABA-ergic modulation rather than growth factor signaling.

Summary Comparison#

Comparison Context#

Dihexa belongs to the Cognitive category of research peptides. Comparing Dihexa with related compounds helps researchers understand its relative positioning in the therapeutic landscape. Each compound has distinct advantages and limitations that should be considered based on the specific research question or clinical need.

Detailed Comparisons#

The following peptides and compounds are most closely related to Dihexa in mechanism, indication, or therapeutic category:

Dihexa vs Semax#

Similarity: Moderate - Both are synthetic peptides studied for cognitive enhancement and neuroprotection

Key Differences: Semax is a heptapeptide ACTH(4-7) analog that modulates BDNF and serotonin pathways, while dihexa is an angiotensin IV derivative that potentiates HGF/c-Met signaling. Semax has extensive clinical use in Russia.

Advantages of Semax: Established safety record from decades of clinical use in Russia, multiple approved formulations, well-characterized mechanism

Disadvantages of Semax: Requires intranasal administration, shorter duration of action, limited Western clinical trial data

Researchers choosing between Dihexa and Semax should consider the development stage, available evidence, and specific research objectives when making their selection.

Dihexa vs Cerebrolysin#

Similarity: Moderate - Both target neurotrophic factor signaling for cognitive enhancement and neuroprotection

Key Differences: Cerebrolysin is a mixture of neurotrophic peptides derived from porcine brain tissue administered intravenously, while dihexa is a defined single compound with oral bioavailability.

Advantages of Cerebrolysin: Extensive clinical trial data including stroke and Alzheimer's studies, approved in multiple countries, well-characterized safety profile

Disadvantages of Cerebrolysin: Requires intravenous administration, animal-derived product, undefined peptide mixture

Researchers choosing between Dihexa and Cerebrolysin should consider the development stage, available evidence, and specific research objectives when making their selection.

Dihexa vs PE-22-28#

Similarity: Moderate - Both are small synthetic peptides targeting neurogenesis and synaptic plasticity in preclinical research

Key Differences: PE-22-28 is a TREK-1 channel antagonist derived from spadin that promotes BDNF expression, while dihexa potentiates HGF/c-Met signaling. Both remain preclinical.

Advantages of PE-22-28: Higher target specificity for TREK-1 channels, rapid BDNF increase, distinct ion channel mechanism

Disadvantages of PE-22-28: Also entirely preclinical, requires subcutaneous administration, limited cognitive enhancement data compared to dihexa

Researchers choosing between Dihexa and PE-22-28 should consider the development stage, available evidence, and specific research objectives when making their selection.

Dihexa vs Selank#

Similarity: Low-Moderate - Both are synthetic peptides with cognitive and neuroprotective properties

Key Differences: Selank is a tuftsin analog with anxiolytic and nootropic properties acting primarily through GABA and serotonin modulation, while dihexa targets growth factor signaling.

Advantages of Selank: Clinical approval in Russia, well-characterized anxiolytic effects, established intranasal formulation

Disadvantages of Selank: Primarily anxiolytic rather than procognitive, requires intranasal administration, limited Western clinical data

Researchers choosing between Dihexa and Selank should consider the development stage, available evidence, and specific research objectives when making their selection.

Related Reading#

• Dihexa overview and research guide
• Dihexa research evidence
• Dihexa dosing protocols